| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |